Lenalidomide induces degradation of IKZF1 and IKZF3

OncoImmunology

Volumn 3, Issue 7, 2014, Pages

  Krönke, Jan ^a   Hurst, Slater N ^a   Ebert, Benjamin L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Lenalidomide; Pomalidomide; Thalidomide; Ubiquitin

Indexed keywords

IKAROS TRANSCRIPTION FACTOR; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 2; LENALIDOMIDE; POMALIDOMIDE; PROTEIN IKZF1; PROTEIN IKZF3; THALIDOMIDE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CYTOKINE RELEASE; HUMAN; MASS SPECTROMETRY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOMA CELL; NONHUMAN; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; UBIQUITINATION;

EID: 84911428345     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/21624011.2014.941742     Document Type: Article

References (10)

1. Krönke J, Udeshi ND, Narla A, Grauman P, Hurst SN, McConkey M, Svinkina T, Heckl D, Comer E, Li X, et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 2014; 343:301-5; PMID: 24292625; http://dx.doi.org/10.1126/science.1244851
2. Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H. Identification of a primary target of thalidomide teratogenicity. Science 2010; 327:1345-50; PMID: 20223979; http://dx.doi.org/10.1126/science.1177319
3. Lu G, Middleton RE, Sun H, Naniong M, Ott CJ, Mitsiades CS, Wong KK, Bradner JE, Kaelin WG, Jr. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 2014; 343:305-9; PMID: 24292623; http://dx.doi.org/10.1126/science.1244917
4. Gandhi AK, Kang J, Havens CG, Conklin T, Ning Y, Wu L, Ito T, Ando H, Waldman MF, Thakurta A, et al. Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4 (CRBN.). Br J Haematol 2014; 164:811-21; PMID: 24328678; http://dx.doi.org/10.1111/bjh.12708
5. Winandy S, Wu P, Georgopoulos K. A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell 1995; 83:289-99; PMID: 7585946; http://dx.doi.org/10.1016/0092-8674(95)90170-1
6. Yang Y, Shaffer AL, 3rd, Emre NC, Ceribelli M, Zhang M, Wright G, Xiao W, Powell J, Platig J, Kohlhammer H, et al. Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma. Cancer Cell 2012; 21:723-37; PMID: 22698399; http://dx.doi.org/10.1016/j.ccr.2012.05.024
7. Gandhi R, Kumar D, Burns EJ, Nadeau M, Dake B, Laroni A, Kozoriz D, Weiner HL, Quintana FJ. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol 2010; 11:846-53; PMID: 20676092; http://dx.doi.org/10.1038/ni.1915
8. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446:758-64; PMID: 17344859; http://dx.doi.org/10.1038/nature05690
9. Cortes M, Georgopoulos K. Aiolos is required for the generation of high affinity bone marrow plasma cells responsible for long-term immunity. J Exp Med 2004; 199:209-19; PMID: 14718515; http://dx.doi.org/10.1084/jem.20031571
10. Tan X, Calderon-Villalobos LI, Sharon M, Zheng C, Robinson CV, Estelle M, Zheng N. Mechanism of auxin perception by the TIR1 ubiquitin ligase. Nature 2007; 446:640-5; PMID: 17410169; http://dx.doi.org/10.1038/nature05731